← Open Payments lookup

OLAMIJI ADEPARUSI: Open Payments

NPI 1851772107 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,020 in 172 payments from 13 companies in 2025. Trend: 2023 $3,076 · 2024 $3,703 · 2025 $4,020

Food & beverage: $4,014Education: $6
CompanyPaymentsAmount
ABBVIE INC.16$514
Teva Pharmaceuticals USA, Inc.28$506
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$447
Otsuka America Pharmaceutical, Inc.20$425
Janssen Pharmaceuticals, Inc10$371
Vanda Pharmaceuticals Inc.12$360
Axsome Therapeutics, Inc.11$254
Lundbeck LLC10$244
Neurocrine BioSciences, Inc.14$223
Alkermes, Inc.10$201

Products named: VRAYLAR, CAPLYTA, UZEDY, FANAPT, ABILIFY ASIMTUFII, REXULTI, Auvelity, INGREZZA.

Industry payments across TX — which companies pay providers there.